Skip to search formSkip to main contentSkip to account menu

JM 118

Known as: JM-118, JM118 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
IntroductionChemotherapy for advanced well-differentiated carcinoids is characterised by low response rates and short duration of… 
Review
2008
Review
2008
Platinum drugs are major chemotherapeutic agents that are used alone or in combination with other systemic agents and/or… 
Highly Cited
2005
Highly Cited
2005
The hydrolysis process of the anticancer drug cis-amminedichlorocyclohexylamineplatinum(II) (JM118 or cis-[PtCl2(NH3… 
Highly Cited
2002
Highly Cited
2002
HeadingAbstractPurpose. Satraplatin is an orally administered platinum complex that has demonstrated clinical activity and… 
Review
2000
Review
2000
  • L. Kèlland
  • Expert Opinion on Investigational Drugs
  • 2000
  • Corpus ID: 36651356
This update focuses on the clinical development of the first orally available platinum-containing anticancer drug, satraplatin… 
Highly Cited
1996
Highly Cited
1996
Abstract This study evaluates the metabolic profile of JM216 [bis(acetato)ammine-dichloro(cyclohexylamine) platinum(IV)], the… 
1996
1996
This study evaluates the metabolism of the oral platinum drug JM216 [bis(acetato) amminedichloro (cyclohexylamine)platinum (IV… 
Highly Cited
1995
Highly Cited
1995
We have investigated the comparative initial DNA binding properties of 7 platinum‐based anticancer drugs: 5 cis‐oriented… 
Highly Cited
1995
Highly Cited
1995
The mechanisms by which cis-diamminedichloroplatinum(II) (cisplatin) is transported across the plasma membrane (i.e., passive…